Glycologix
Beverly
About Glycologix
Glycologix is a biotechnology company that focuses on locally delivered biopolymers for soft tissue protection. Replenishing naturally occurring proteoglycans can help with a variety of unmet medical conditions. Its platform discovery engine makes it possible to create synthetic structural mimics of proteoglycans. These novel materials are highly soluble despite their high molecular weight, allowing for optimal tissue coverage. Interstitial cystitis, dry eye, post-surgical adhesion prevention, osteoarthritis, spinal disk disease, and wound repair are among the platform's targeted indications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.2M
- Last round: Series Unknown (Dec 2025)
- Website: glycologix.com
- Phone: 617-275-1765
Industries & Categories
Advanced Materials, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/glycologix-104682 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.